Loading
Latest filing published 10 Apr 2026 for Pharma Mar, S.A., €9,952.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
María Concepción Sanz López, listed as chief executive, appears in our data through filings on Pharma Mar, S.A. shares, published by CNMV. Over a trading history stretching from 25 June 2020 to 26 March 2026, the count stands at 3 filings.
In open-market terms, that means 1 purchase worth €20k on one side and 1 sale worth €20k on the other. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 10 April 2026 with a transaction (€9,952) in Pharma Mar, S.A. The clock since the last published purchase (30 June 2020) now reads 2,307 days. Filings reach the CNMV feed a median of 5 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by CNMV. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration